CanSino Financial Statements From 2010 to 2026

Stocks . Germany . 
Stock . CanSino Biologics
CJH Stock   3.66  0.06  1.61%   
Analyzing historical trends in various income statement and balance sheet accounts from CanSino Biologics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting CanSino Biologics' valuation are summarized below:
Gross Profit
721.5 M
Profit Margin
(0.15)
Market Capitalization
1.3 B
Enterprise Value Revenue
11.2714
Revenue
971.8 M
There are currently seventy-eight fundamental signals for CanSino Biologics that can be evaluated and compared over time across rivals. All traders should validate CanSino Biologics' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

CanSino Biologics Total Revenue

797.25 Million

Check CanSino Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CanSino Biologics' main balance sheet or income statement drivers, such as Tax Provision of 2.3 M, Net Interest Income of 4.1 M or Interest Income of 44.4 M, as well as many indicators such as . CanSino financial statements analysis is a perfect complement when working with CanSino Biologics Valuation or Volatility modules.
  
This module can also supplement various CanSino Biologics Technical models . Check out the analysis of CanSino Biologics Correlation against competitors.

CanSino Biologics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.3 B9.2 B4 B
Slightly volatile
Other Current Liabilities769.2 M732.5 M261.1 M
Slightly volatile
Total Current Liabilities1.3 B2 B850.6 M
Slightly volatile
Total Stockholder Equity4.1 B5.6 B2.6 B
Slightly volatile
Other Liabilities268.5 M255.7 M106.3 M
Slightly volatile
Net Tangible Assets7.9 B7.5 B3.1 B
Slightly volatile
Accounts Payable68.3 M71.8 M87.2 M
Slightly volatile
Cash2.1 B1.8 B1.3 B
Slightly volatile
Non Current Assets Total2.2 B4.2 B1.5 B
Slightly volatile
Other Assets481.5 M458.5 M153.3 M
Slightly volatile
Long Term Debt1.3 B1.3 B390.3 M
Slightly volatile
Net Receivables890.7 M848.3 M245.2 M
Slightly volatile
Short Term Investments1.3 B1.9 B833.6 M
Slightly volatile
Non Current Liabilities Total1.5 B1.5 B519.7 M
Slightly volatile
Other Stockholder Equity103.5 K108.9 K99.2 M
Slightly volatile
Total Liabilities2 B3.5 B1.3 B
Slightly volatile
Total Current Assets4.1 B4.9 B2.6 B
Slightly volatile
Intangible Assets328 M312.3 M113.8 M
Slightly volatile
Property Plant Equipment3.7 B3.5 B1.3 B
Slightly volatile
Net Debt283.4 M499.4 M241.1 M
Slightly volatile
Non Currrent Assets Other417 M397.1 M172.3 M
Slightly volatile
Common Stock Shares Outstanding260.7 M284.6 M233.5 M
Slightly volatile
Other Current Assets181.3 M281.8 M115 M
Slightly volatile
Deferred Long Term Liabilities41.5 M59.7 M34.2 M
Slightly volatile
Net Invested Capital5.8 B7.9 B3.6 B
Slightly volatile
Short and Long Term Debt688.1 M1 B395.3 M
Slightly volatile
Net Working Capital3.1 B2.9 B1.8 B
Slightly volatile
Common Stock235.1 M284.6 M199.5 M
Slightly volatile
Capital Stock254.7 M284.6 M202.8 M
Slightly volatile
Property Plant And Equipment Net2.3 B3.1 B1.4 B
Slightly volatile
Capital Lease Obligations24.8 M26.1 M58.4 M
Slightly volatile
Property Plant And Equipment Gross2.6 B3.6 B1.6 B
Slightly volatile

CanSino Biologics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income4.1 M4.3 M9.3 M
Slightly volatile
Interest Income44.4 M73.5 M28.4 M
Slightly volatile
Selling General Administrative680.3 M647.9 M213.3 M
Slightly volatile
Other Operating Expenses10.1 M9.6 M3.9 M
Slightly volatile
Cost Of Revenue535.2 M281.1 M323.8 M
Slightly volatile
Total Operating Expenses1.2 B1.3 B726.1 M
Slightly volatile
Research Development477.5 M478.5 M288.6 M
Slightly volatile
Reconciled Depreciation255.2 M243.1 M82.2 M
Slightly volatile

CanSino Biologics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation255.2 M243.1 M78.7 M
Slightly volatile
Capital Expenditures518.3 M526.3 M355.4 M
Slightly volatile
Change To Operating Activities2.3 M2.4 M5.3 M
Very volatile
End Period Cash Flow2.1 B1.8 B1.3 B
Slightly volatile
Other Cashflows From Investing Activities129.4 M123.2 M48.6 M
Slightly volatile
Begin Period Cash Flow2.1 B2.4 B1.2 B
Slightly volatile
Dividends Paid60.8 M113.6 M42.5 M
Slightly volatile
Total Cash From Financing Activities1.6 B982.4 M982.1 M
Slightly volatile
Stock Based Compensation2.7 M2.9 M15.9 M
Slightly volatile

About CanSino Biologics Financial Statements

CanSino Biologics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although CanSino Biologics investors may analyze each financial statement separately, they are all interrelated. The changes in CanSino Biologics' assets and liabilities, for example, are also reflected in the revenues and expenses on on CanSino Biologics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue948.6 M797.3 M
Cost Of Revenue281.1 M535.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for CanSino Stock Analysis

When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY